155 related articles for article (PubMed ID: 26256930)
1. [Cutaneous extramedullary hematopoiesis associated with myelodysplastic/myeloproliferative neoplasm, unclassifiable].
Yoshida M; Horiuchi M; Ueda H; Hagihara K; Kanashima H; Nakao T; Hirata C; Inoue T; Yamane T
Rinsho Ketsueki; 2015 Jul; 56(7):911-4. PubMed ID: 26256930
[TBL] [Abstract][Full Text] [Related]
2. Extramedullary myelodysplastic/myeloproliferative neoplasm (MDS/MPN) with ring sideroblasts and thrombocytosis.
Kerneves P; Cornet E; Paubelle E
Int J Lab Hematol; 2021 Oct; 43(5):890-891. PubMed ID: 33586865
[No Abstract] [Full Text] [Related]
3. Cutaneous extramedullary hematopoiesis in a patient with idiopathic myelofibrosis.
Miyata T; Masuzawa M; Katsuoka K; Higashihara M
J Dermatol; 2008 Jul; 35(7):456-61. PubMed ID: 18705835
[TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): More than just a "catch-all" term?
Shallis RM; Zeidan AM
Best Pract Res Clin Haematol; 2020 Jun; 33(2):101132. PubMed ID: 32460977
[TBL] [Abstract][Full Text] [Related]
5. Clinical analysis and literature review of a case with the myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.
Long B; Shi H; Zhu C
Hematology; 2020 Dec; 25(1):283-285. PubMed ID: 32657243
[No Abstract] [Full Text] [Related]
6. Recurrent bilateral adrenal infarction with myelodysplastic/myeloproliferative neoplasm-unclassifiable (MDS/MPN-U): a case report.
Hoshino Y; Manaka K; Sato J; Asatsuma Y; Horikoshi H; Takeuchi M; Ito N; Fujita M; Yasunaga M; Matsuda K; Honda A; Maki H; Masamoto Y; Kurokawa M; Nangaku M; Makita N
BMC Endocr Disord; 2023 Jun; 23(1):128. PubMed ID: 37277771
[TBL] [Abstract][Full Text] [Related]
7. [Idiopathic myelofibrosis with cutaneous extramedullary hematopoiesis].
Rodríguez Ramírez J; Redondo Martínez E; Bosch Benítez J; López Mirones E; Gómez Díaz J; Betancor León P
Med Clin (Barc); 1991 Jun; 97(1):24-6. PubMed ID: 1857143
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta overexpression in cutaneous extramedullary hematopoiesis of a patient with myelodysplastic syndrome associated with myelofibrosis.
Kawakami T; Kimura S; Kato M; Mizoguchi M; Soma Y
J Am Acad Dermatol; 2008 Apr; 58(4):703-6. PubMed ID: 18342720
[TBL] [Abstract][Full Text] [Related]
9. Janus kinase 2 V617F mutation is detectable in spleen of patients with chronic myeloproliferative diseases suggesting a malignant nature of splenic extramedullary hematopoiesis.
Konoplev S; Hsieh PP; Chang CC; Medeiros LJ; Lin P
Hum Pathol; 2007 Dec; 38(12):1760-3. PubMed ID: 17707884
[TBL] [Abstract][Full Text] [Related]
10. [Idiopathic myelofibrosis with extramedullary hematopoiesis foci in the skin and testicles. Report of a case].
Ruberto E; Espinola R; Brusco J; Bacchiocchi M; Zoppi J; Paz R
Sangre (Barc); 1995 Apr; 40(2):157-60. PubMed ID: 7784946
[TBL] [Abstract][Full Text] [Related]
11. JAK2-positive cutaneous myelofibrosis presenting as sclerosing extramedullary hematopoietic tumors on the scalp: case presentation and review of the literature.
LeBlanc RE; Lester L; Kwong B; Rieger KE
J Cutan Pathol; 2015 Nov; 42(11):858-62. PubMed ID: 26153565
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of Differentially Expressed Signaling Pathway Proteins in Myelodysplastic/Myeloproliferative Neoplasms-Unclassifiable].
Hui WH; Ye F; Zhang W; Liu CY; Xu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1062-8. PubMed ID: 26314447
[TBL] [Abstract][Full Text] [Related]
13. Fine-needle aspiration diagnosis of clonal extramedullary hematopoiesis in a case of myeloproliferative neoplasm.
Shponka V; Bone K; Nomani L; Hunt B
Diagn Cytopathol; 2022 Feb; 50(2):E43-E46. PubMed ID: 34617678
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous myelofibrosis with JAK2 V617F mutation: metastasis, not merely extramedullary hematopoiesis!
Fraga GR; Caughron SK
Am J Dermatopathol; 2010 Oct; 32(7):727-30. PubMed ID: 20859081
[TBL] [Abstract][Full Text] [Related]
15. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.
Pizzi M; Gergis U; Chaviano F; Orazi A
Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):96-104. PubMed ID: 27521149
[TBL] [Abstract][Full Text] [Related]
16. Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms.
Büttner-Herold M; Sticht C; Wiech T; Porubsky S
Histopathology; 2021 Apr; 78(5):738-748. PubMed ID: 33078472
[TBL] [Abstract][Full Text] [Related]
17. [Cutaneous extramedullary hematopoiesis in idiopathic myelofibrosis. Description of a case].
Del Forno C; Borroni G; Caresana G; Nalli G; Barosi G
G Ital Dermatol Venereol; 1990 May; 125(5):205-9. PubMed ID: 2253954
[TBL] [Abstract][Full Text] [Related]
18. The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features.
Orazi A; Germing U
Leukemia; 2008 Jul; 22(7):1308-19. PubMed ID: 18480833
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous involvement in Ph-negative myeloproliferative neoplasms: from extramedullary hematopoiesis to myeloid metastasis with histiocytic differentiation. A systematic review of the literature.
Bonometti A
Int J Dermatol; 2023 Oct; 62(10):1228-1236. PubMed ID: 37649236
[TBL] [Abstract][Full Text] [Related]
20. Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms.
Person F; Meyer SC; Hopfer H; Menter T
Virchows Arch; 2021 Nov; 479(5):1013-1020. PubMed ID: 34164707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
